Clinical Phenotype of Large 22q Deletion Encompassing FGFR3
A large 22q deletion encompassing the FGFR3 gene presents as 22q11.2 deletion syndrome (22q11.2DS), not as an FGFR3-related skeletal dysplasia, because the hemizygous loss of FGFR3 does not cause achondroplasia or related conditions—these require gain-of-function mutations, not deletions. 1, 2
Understanding the Genetic Context
The confusion in this question stems from conflating two distinct genetic mechanisms:
- FGFR3 gain-of-function mutations cause skeletal dysplasias (achondroplasia, hypochondroplasia, thanatophoric dysplasia) through receptor hyperactivation 3, 4
- 22q11.2 deletions that include FGFR3 cause 22q11.2DS through haploinsufficiency of multiple genes, but FGFR3 loss does not contribute to the skeletal phenotype 1, 2
Core Clinical Presentation of 22q11.2 Deletion Syndrome
Multisystem Features in Children and Adolescents
Congenital and Early-Onset Features:
- Cardiac anomalies (congenital heart defects, particularly conotruncal abnormalities) 2
- Palatal abnormalities (cleft palate, velopharyngeal incompetence, submucous cleft) 2, 5
- Immunodeficiency (thymic hypoplasia/aplasia, recurrent infections) 2
- Hypocalcemia (parathyroid hypoplasia) 1, 2
- Feeding difficulties and failure to thrive in infancy 2
Craniofacial and Dental:
- Subtle dysmorphic features (not the prominent features seen in FGFR3 skeletal dysplasias)
- Enamel hypoplasia, hypomineralization, dental agenesis 5
- Cleft lip/palate (when present) 5
Neurodevelopmental and Cognitive Profile:
- Intellectual disability with most common full-scale IQ in borderline range (70-85) 1
- Average 30-point IQ deficit relative to parental IQ 1
- Developmental delay universally present 2
- Speech and language deficits (delayed or absent expressive speech) 2
- Executive function impairments (problem-solving, working memory, impulse control) 1
- Concrete/literal thinking, difficulty with social cognition 1
Psychiatric and Behavioral Manifestations (Adolescence and Adulthood)
High-Risk Neuropsychiatric Features:
- Anxiety disorders 1
- Psychotic disorders (significantly elevated risk) 1
- Mood disorders 2
- Autism spectrum features 2
- Emotional immaturity and impulsivity 1
- Social vulnerability (bullying, exploitation, poor judgment) 1, 2
Additional Organ System Involvement
Genitourinary: Congenital anomalies, renal cysts, potential renal failure 1
Hematologic: Mild-moderate thrombocytopenia, immune thrombocytopenia, impaired hemostasis 1
Endocrine: Thyroid disorders, growth abnormalities, metabolic issues 1
Musculoskeletal: Scoliosis risk, orthopedic issues (distinct from FGFR3 skeletal dysplasias) 1, 2
Gastrointestinal: Variable manifestations including potential Hirschsprung disease 2
Critical Distinction: Why FGFR3 Deletion ≠ FGFR3 Mutation Phenotype
FGFR3 skeletal dysplasias require constitutive receptor activation through specific missense mutations (e.g., p.Gly380Arg in achondroplasia) that cause ligand-independent signaling, enhanced dimerization, and sustained MAPK/ERK pathway activation 3, 4.
Haploinsufficiency (one deleted copy) does not produce this effect—patients with 22q11.2 deletions do not exhibit:
- Disproportionate short stature with rhizomelic limb shortening
- Macrocephaly with frontal bossing (as seen in achondroplasia)
- Bowed legs characteristic of FGFR3 gain-of-function
- Growth plate dysfunction from FGFR3 hyperactivation 3, 4
Essential Clinical Workup at Diagnosis
Immediate Assessments Required: 1, 2
- Genetic confirmation: FISH, MLPA, or chromosomal microarray
- Cardiac evaluation: Echocardiogram (congenital heart disease screening)
- Immunologic: CBC with differential, lymphocyte subsets, immunoglobulin levels
- Endocrine: Calcium (ionized, pH-corrected), magnesium, PTH, TSH
- Renal: Creatinine, abdominal ultrasound
- ENT/Audiology: Hearing assessment, palatal examination
- Developmental: Formal neurocognitive and adaptive functioning assessment
Subspecialty Coordination:
- Genetics, cardiology, immunology, endocrinology, ENT, speech-language pathology, developmental pediatrics, psychiatry (as age-appropriate) 1, 2
Surveillance and Long-Term Management
Ongoing monitoring every 1-2 years includes: 1
- Psychiatric screening (anxiety, psychosis, mood disorders)
- Neurologic assessment (seizures, movement disorders)
- Endocrine surveillance (thyroid, calcium, metabolic parameters)
- Hematologic monitoring (CBC, especially preoperatively)
- Cardiovascular risk assessment
- Developmental and adaptive functioning reassessment
Common Pitfalls to Avoid
- Do not expect FGFR3 skeletal dysplasia features in 22q11.2DS patients—the deletion does not cause achondroplasia phenotype
- Do not overlook psychiatric screening in adolescence—this is when psychotic disorders emerge with highest risk 1, 2
- Recognize social vulnerability—impaired judgment, impulsivity, and desire for friendship create exploitation risk 1, 2
- Screen for late-onset manifestations—many features emerge or worsen over time 1
- Coordinate multidisciplinary care—fragmented care misses evolving complications 1, 2